Cel-Sci
CVM
#10549
Rank
ยฃ15.48 M
Marketcap
ยฃ0.89
Share price
-0.84%
Change (1 day)
-82.62%
Change (1 year)

Cel-Sci (CVM) - Total assets

Total assets on the balance sheet as of March 2026 : ยฃ13.29 Million

According to Cel-Sci 's latest financial reports the company's total assets are ยฃ13.29 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Cel-Sci - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-09-30ยฃ20.94 M3.79%
2024-09-30ยฃ20.17 M-19.38%
2023-09-30ยฃ25.02 M-44.88%
2022-09-30ยฃ45.4 M-19.39%
2021-09-30ยฃ56.32 M79.49%
2020-09-30ยฃ31.38 M39.62%
2019-09-30ยฃ22.47 M-0.95%
2018-09-30ยฃ22.69 M32.6%
2017-09-30ยฃ17.11 M-10.87%
2016-09-30ยฃ19.19 M1.69%
2015-09-30ยฃ18.87 M59.18%
2014-09-30ยฃ11.86 M77.13%
2013-09-30ยฃ6.69 M-32.8%
2012-09-30ยฃ9.96 M-16.45%
2011-09-30ยฃ11.92 M-50.42%
2010-09-30ยฃ24.05 M-16.9%
2009-09-30ยฃ28.94 M248.89%
2008-09-30ยฃ8.29 M-18.19%
2007-09-30ยฃ10.14 M96.69%
2006-09-30ยฃ5.15 M193.68%
2005-09-30ยฃ1.75 M-42.72%
2004-09-30ยฃ3.06 M75.22%
2003-09-30ยฃ1.74 M-27.64%
2002-09-30ยฃ2.41 M-21.08%
2001-09-30ยฃ3.06 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
ยฃ150.83 B 1,134,426.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ69.45 B 522,306.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
ยฃ0.55 B 4,061.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
ยฃ22.28 M 67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ30.06 B 226,021.43%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
ยฃ0.34 B 2,526.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.99 B 7,356.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
ยฃ7.91 M-40.46%๐Ÿ‡บ๐Ÿ‡ธ USA